Concepedia

T. Ory

TO

3

Publications

301

Citations

3

H-Index

2005

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

T. Ory is an author at GlaxoSmithKline (Belgium) specializing in tumor biology, radiation oncology, and medicine.

Top concepts

MedicineTumor BiologyRadiation OncologyOncologyPathologyCell DeathImmunologyCell BiologyInflammationBreast Cancer

Publications per year

2005–2015

3

Publications

3

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells

Wenle Xia, Catherine Gérard, Lei-Hua Liu et al. · Oncogene · 2005 · 262 citations

Breast Oncology, Medicine, Receptor Tyrosine Kinase +11

Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses

Catherine Gérard, Nathalie Baudson, T. Ory et al. · PLoS ONE · 2014 · 27 citations · Full text

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors

Catherine Gérard, Nathalie Baudson, T. Ory et al. · Journal of Immunotherapy · 2015 · 12 citations · Full text

Comprehensive Preclinical Model, Immunology, Immunoediting +20

Rows per page

1–3 of 3